Vopr Kurortol Fizioter Lech Fiz Kult. 2007 Sep-Oct;(5):24-6.
Infitatherapy of children with bronchial asthma
[Article in Russian]
Konova OM, Markarov GS, Zaslavski? AIu.
Use of nonmedicamental methods of treatment assists to improve the control of children’s bronchial asthma clinical course. Pulsed low-frequency electromagnetic field regulates the state of central and vegetative nervous system and improves psychological status of child. Inphytotherapy has bronchial spasmolytic and immune correction effects.
|Acta Physiol Hung. 2003;90(4):327-34.|
The effect of the pulsatile electromagnetic field in children suffering from bronchial asthma.
Sadlonova J, Korpas J, Salat D, Miko L, Kudlicka J.
Ist Internal Clinic, Teaching Hospital Martin, Martin, Slovakia. email@example.com
From the bibliography it is well known that pulsatile electromagnetic field has an anti-inflammatory and analgesic effect. It causes vasodilatation, myorelaxation, hyper-production of connective tissue and activation of the cell membrane. Therefore our aim was to study the possible therapeutic effect of pulsatile electromagnetic field in asthmatic children. Forty-two children participating in this study were divided in two groups. The 1st group consisting of 21 children (11 females, 10 males, aged 11.8 +/- 0.4 yr) was treated by pulsatile electromagnetic field and pharmacologically. The 2nd group served as control, consisting also of 21 children (11 females, 10 males, aged 11.7 +/- 0.3 yr) and was treated only pharmacologically. Therapeutic effect of the pulsatile electromagnetic field was assessed on the basis of pulmonary tests performed by means of a Spirometer 100 Handi (Germany). The indexes FVC, IVC, ERV, IRV, FEV1, FEV1/FVC%, MEF75,50,25, PEF, PIF and the changes of the flow-volume loop were also registered. The pulsatile electromagnetic field was applied by means of the device MTU 500H, Therapy System (Brno, Czech Republic) for 5 days, two times daily for 30 minutes (magnetic induction: 3 mT, frequency: 4 Hz as recommended by the manufacturer). The results in children of the 1st group showed an improvement of FVC of about 70 ml, IVC of about 110 ml, FEV1 of about 80 ml, MEF75 of about 30 ml, PEF of about 480 ml, PIF of about 550 ml. The increases of ERV, IRV and FEV1/FVC and decreases of MEF25,50 were statistically insignificant. The results in the 2nd group were less clear. The flow-volume loop showed a mild improvement in 14 children. This improvement in the 2nd group was less significant. The clinical status of children and their mood became better. We believe that the pulsatile electro-magnetotherapy in children suffering from asthma is effective. On the basis of our results we can recommend it as a complementary therapy.
Bratisl Lek Listy. 2002;103(7-8):260-5.
The effect of the pulsatile electromagnetic field in patients suffering from chronic obstructive pulmonary disease and bronchial asthma.
Sadlonova J, Korpas J, Vrabec M, Salat D, Buchancova J, Kudlicka J.
Department of Internal Medicine, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia. firstname.lastname@example.org
Pulsatile electromagnetotherapy (PETh) stimulates biological tissues and processes; it modulates ion exchange across cell membranes and thus regulates the tone of smooth muscles. On the basis of these effects we hypothetized that PETh might treat COPD and bronchial asthma. We examined 117 (61 females, 56 males) adult patients who were decided in 4 groups. The 1st consisted of 16 patients with COPD who were treated by PETh and pharmacologically. The 2nd group (control) consisted of 24 patients with COPD who were treated only with medicaments. The 3rd group consisted of 37 asthmatics, treated by PETh and medicaments. The 4th group (control) consisted of 40 asthmatics treated only with medicaments. The effectiveness of PETh was assessed by lung function tests, which were performed using a Spirometer 100 Handi (Germany). We measured FVCex, FEV1, percentage of FEV1/FVCex, MEF25, 50, 75, PEF and registered the flow-volume loops. PETh was applied by apparatus MTU 500H (Therapy System, Czech Republic). It was administered 10 doses; once daily for 20 min, with a frequency of 4.5 Hz and a magnetic induction 3 T. The initial 3 doses were about 25% lower then the later doses. PETh was very effective in patients with COPD. The measured indexes improved about 200-660 ml or ml x s(-1), except FVC. PETh was less effective in asthmatics. Most indices improved without statistical significance, about 50-620 ml or ml x s(-1). The indices of FEV1/FVC and MEF25 deteriorated. The changes in controls without PETh were very small. (Tab. 2, Fig. 1, Ref. 19.)
|Bratisl Lek Listy. 2000;101(2):71-7.|
The sensitivity of tussinphonography for assessing the effectiveness of treatment.
Korpas J, Salat D, Sadlonova J, Vrabec M, Kudlicka J.
Department of Pathophysiology, Jessenius Medical School Martin, Slovakia.
Our previous studies have demonstrated that tussiphonogram is suitable not only for the detection of pathological condition in the respiratory tract but also for treatment effectiveness assessment. The purpose of this study was to evaluate the possibilities of tussiphonography in detection of already little pathological changes in the airways and lungs. Therefore the changes of voluntary cough sound indexes were compared with pulmonary function tests in selected group of asthmatics before and after a pulsatile electromagnetic therapy in which the effect of therapy on pulmonary function tests was minimal. After magnetotherapy in 18 patients with increased expiratory forced lung capacity by 7.3% and increased peak inspiratory flow by 31.7% in average the voluntary cough sound intensity decreased by 37.8%, the sound duration shortened by 11% and the sound pattern showed the tendency to normalization. The improvement of mentioned cough indexes was absent in 17 patients who were treated by magnetotherapy too, but at the same time suffered from respiratory viral infection and in 22 patients treated only with climatotherapy and antiasthmatics. Changes of flow-volume loops in patients were not in the close relation to other followed indices. The correlation analysis showed a functional connection in relative differences of cough sound indices and some pulmonary function tests. The results confirmed the suitability of tussiphonography to indicate even mild pathological changes in respiratory tract. (Fig. 4, Ref. 21.)
Vopr Kurortol Fizioter Lech Fiz Kult. 1996 Mar-Apr;(2):13-5.
The rehabilitative treatment of children with bronchial asthma
[Article in Russian]
Alymkulov DA, To?chieva FM, Saralinova GM, Le?kina LF.
Staged regimen of decimetric wave electromagnetic therapy and microclimate of high altitude salt mines were used in sanatorium treatment of children with bronchial asthma. Pretreatment with the above magnetic field induced positive changes in the reflex-segmental zone which reflected in better adaptation to the high altitude climate. The latter promoted beneficial rearrangement of respiratory function and cardiovascular system.
Vopr Kurortol Fizioter Lech Fiz Kult. 1995 Nov-Dec;(6):16-8.
The efficacy of using an electromagnetic field of extremely high frequency (54-78 GHz) in treating patients with chronic nonspecific lung disease.
[Article in Russian]
Danilenko SR, Shatrov AA, Gerasimovich OI.
After a trial of the therapeutic complex including extra high frequency electromagnetic field in 154 patients with chronic bronchitis and bronchial asthma high efficacy of EHF-therapy was stated in the above diseases.
Vopr Kurortol Fizioter Lech Fiz Kult. 1994 May-Jun;(3):6-10.
A validation for the combined transcerebral exposure to a UHF electrical field and to decimeter waves in the area of the splenic projection in bronchial asthma.
[Article in Russian]
Maliavin AG, Rychkova MA, Nikoda NV.
Thirty patients with bronchial asthma of moderate severity in unstable remission were treated with transcerebral UHF electric field and decimeter waves on the spleen region. Clinical and laboratory postexposure findings provided evidence in favour of the regimens used. Tolerance of the procedures, comparative efficacy regarding the clinico-pathogenetic variant, probable mechanisms of therapeutic action are discussed.